Vaishali Pharma Limited (NSE:VAISHALI)

Market Cap	1.57B
Revenue (ttm)	1.05B
Net Income (ttm)	3.98M
Shares Out	130.46M
EPS (ttm)	0.03
PE Ratio	395.39
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	139,583
Average Volume	431,902
Open	12.05
Previous Close	12.17
Day's Range	12.01 - 12.40
52-Week Range	10.30 - 24.91
Beta	0.36
RSI	46.65
Earnings Date	Nov 10, 2025

About Vaishali Pharma

Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers active pharmaceutical ingredients (APIs), including antibiotics, anti-ulcer, anti-inflammatory/analgesic/anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, anti-diarrheal/anti-protozoal/anti-parasitic, anti-viral, anti-epileptic, anti-asthmatic, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helmintic drugs, as well as excipients, topical steroids, corticosteroids, and enzymes. The company also ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 27
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VAISHALI

Financial Performance

In 2024, Vaishali Pharma's revenue was 990.26 million, an increase of 14.77% compared to the previous year's 862.80 million. Earnings were 8.17 million, an increase of 13.70%.